Mònica Sánchez-Guixé

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

Cancer discovery

Nature communications

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mandy Lawson, Natalie Cureton, Susana Ros, Azadeh C Bashi, Jelena Urosevic, Sophie D'Arcy, Oona Delpuech, Michelle DuPont, David I Fisher, Eric T Gangl, Hilary J Lewis, Dawn Trueman, Neha Wali, Stuart Charles Williamson, Jennifer I Moss, Elodie Montaudon, Héloïse Derrien, Elisabetta Marangoni, Ricardo J Miragaia, Sladjana Gagrica, Pablo Morentin Gutierrez, Thomas Moss, Gareth A Maglennon, Daniel Sutton, Radoslaw Polanski, Alan Rosen, Jonathan Cairns, Pei Zhang, Mònica Sánchez-Guixé, Violeta Serra, Susan E Critchlow, James S Scott, Justin P O Lindemann, Simon T Barry, Teresa Klinowska, Christopher J Morrow, Larissa S Carnevalli
The next-generation oral selective estrogen receptor degrader camizestrant (AZD9833) suppresses ER+ breast cancer growth and overcomes endocrine and CDK4/6 inhibitor resistance. Cancer research (2023)
Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Nuria Lopez-Bigas, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández-Losa, Faye Su, Kui Lin, Robert B Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C Turner, Aleix Prat, Paolo G Nuciforo, Rodrigo Dienstmann, Chandra S Verma, Núria López-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer. Nature communications 13 (1) (2022)
Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Nuria Lopez-Bigas, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández-Losa, Faye Su, Kui Lin, Robert B Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C Turner, Aleix Prat, Paolo G Nuciforo, Rodrigo Dienstmann, Chandra S Verma, Núria López-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer. Nature communications 13 (1) (2022)
Mònica Sánchez-Guixé, Cinta Hierro, José Jiménez, Cristina Viaplana, Guillermo Villacampa, Erika Monelli, Fara Brasó-Maristany, Zighereda Ogbah, Mireia Parés, Marta Guzmán, Judit Grueso, Olga Rodríguez, Mafalda Oliveira, Analía Azaro, Elena Garralda, Josep Tabernero, Oriol Casanovas, Maurizio Scaltriti, Aleix Prat, Rodrigo Dienstmann, Paolo G Nuciforo, Cristina Saura, Mariona Graupera, Ana Vivancos, Jordi Rodon, Violeta Serra
High FGFR1-4 mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)